MUMBAI, India, Sept. 22 -- Intellectual Property India has published a patent application (202617073418 A) filed by Genzyme Corporation on June 12, 2026, for Methods Of Treating Gaucher Disease And Gba-Parkinson'S Disease.
Inventors include Ayloo, Swathi; and Ramachandran, Shyam.
The application for the patent was published on September 18, 2026, under issue no. 38/2026.
Abstract: Provided herein are expression cassettes for expressing a transgene in a cell, wherein the transgene encodes a GCase polypeptide. Also provided are methods to treat Gaucher Disease or GBA-PD. Further provided herein are vectors (e.g., rAAV vectors), viral particles, pharmaceutical compositions, and kits for expressing an GCase polypeptide in an individual in need thereof.
Disclaimer: Curated by HT Syndication.
